Scientists imagine that combining navitoclax with ruxolitinib can help individuals with myelofibrosis. During this trial half the people have navitoclax and ruxolitinib. One other fifty percent have ruxolitinib in addition to a dummy drug (placebo ). software, a video series that functions specialists delving into essential analysis results offered at https://fredt909hsd3.wikijm.com/user